SIGNATUREFD, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,612
-72.7%
838
-39.8%
0.00%
-100.0%
Q2 2023$35,257
-21.4%
1,3930.0%0.00%0.0%
Q1 2023$44,869
+1458.0%
1,393
+792.9%
0.00%
Q4 2022$2,880
-58.9%
156
-36.8%
0.00%
Q3 2022$7,000
+250.0%
247
+126.6%
0.00%
Q2 2022$2,0000.0%109
+28.2%
0.00%
Q1 2022$2,000
-66.7%
85
-76.4%
0.00%
Q4 2021$6,000
+200.0%
360
+445.5%
0.00%
Q3 2021$2,0000.0%66
-18.5%
0.00%
Q2 2021$2,0000.0%81
+22.7%
0.00%
Q1 2021$2,0000.0%660.0%0.00%
Q4 2020$2,0000.0%660.0%0.00%
Q3 2020$2,0000.0%660.0%0.00%
Q2 2020$2,000
+100.0%
660.0%0.00%
Q1 2020$1,0000.0%660.0%0.00%
Q4 2019$1,0000.0%660.0%0.00%
Q3 2019$1,0000.0%660.0%0.00%
Q2 2019$1,000660.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders